Medroxyprogesterone Acetate
Showing 1 - 25 of 1,214
Abnormal Uterine Bleeding, Tranexamic Acid, Estrogen Trial in Bangkok, Phaya Thai (Tranexamic acid 250 mg oral tablet, Progynova
Not yet recruiting
- Abnormal Uterine Bleeding
- +3 more
- Tranexamic acid 250 mg oral tablet
- Progynova 1 mg oral tablet
-
Bangkok, Ratchathewi, Thailand
- +1 more
Sep 27, 2023
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma Stage I
- Medroxyprogesterone acetate + Atorvastatin
-
Peking, Beijing, ChinaWang Jianliu
Dec 29, 2022
Infertility Trial in Istanbul (Gonadotropin releasing hormone antagonist (Cetrotide), Medroxyprogesterone Acetate (Tarlusal),
Not yet recruiting
- Infertility
- Gonadotropin releasing hormone antagonist (Cetrotide)
- +2 more
-
Istanbul, TurkeyBezmialem Vakif University
Mar 13, 2023
Contraception Trial (Depot-Medroxyprogestereone Acetate)
Not yet recruiting
- Contraception
- Depot-Medroxyprogestereone Acetate
- (no location specified)
Aug 15, 2022
Fertility Sparing Trial in Beijing (Medroxyprogesterone Acetate 500 MG Oral Tablet, Levonorgestrel-Releasing Intrauterine
Recruiting
- Fertility Sparing
- Medroxyprogesterone Acetate 500 MG Oral Tablet
- Levonorgestrel-Releasing Intrauterine System
-
Beijing, Beijing, ChinaBei Jing Chao-Yang Hospital
Oct 3, 2022
Endometriosis Ovary Trial in Semarang (Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate))
Recruiting
- Endometriosis Ovary
- Dienogest
- +3 more
-
Semarang, Central Java, IndonesiaKariadi Hospital
Nov 22, 2023
Contraception Trial in Cypress, San Antonio (TV-46046, DeposubQ Provera)
Active, not recruiting
- Contraception
- TV-46046
- DeposubQ Provera
-
Cypress, California
- +2 more
Nov 18, 2022
Menorrhagia Trial in Sherbrooke (MPA, )
Terminated
- Menorrhagia
- MPA
- placebo
-
Sherbrooke, Quebec, CanadaCentre Hospitalier Universitaire de Sherbrooke
May 16, 2022
Endometrial Tumor Malignant Stage I Trial in Shanghai (Megestrol Acetate 160 MG Oral Tablet, Medroxyprogesterone Acetate 500 MG,
Recruiting
- Endometrial Neoplasm Malignant Stage I
- Megestrol Acetate 160 MG Oral Tablet
- +3 more
-
Shanghai, Shanghai, China, ChinaObstetrics and Gynecology Hospital, Fudan University
Mar 25, 2022
Hormonal Contraceptive Methods on Immunologic Changes in Female
Recruiting
- Hormonal Contraception
- Depot medroxyprogesterone acetate (DMPA)
- +2 more
-
Atlanta, Georgia
- +2 more
Aug 15, 2022
HRT on Overactive Bladder Symptoms, Sexual Function, Depressive
Recruiting
- Menopausal Syndrome
- Tibolone 2.5 mg
- Estradiol valerate 1 mg/medroxyprogesterone acetate 2.5 mg
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jan 29, 2023
Healthy Trial in Brussels (Sayana Press)
Recruiting
- Healthy
- Sayana Press
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
May 23, 2022
Uterine Bleeding Trial in Assiut (Tranexamic acid, Medroxyprogesterone Acetate 150 MG/ML)
Recruiting
- Uterine Bleeding
- Tranexamic acid
- Medroxyprogesterone Acetate 150 MG/ML
-
Assiut, EgyptWomen Health Hospital - Assiut university
Aug 27, 2021
Infertility Trial in Valencia (Provera 10 mg., Ganirelix (GnRH antagonist))
Completed
- Infertility
- Provera 10 mg.
- Ganirelix (GnRH antagonist)
-
Valencia, SpainIVI Valencia
Aug 24, 2021
Drug-drug Interactions Between Hormonal Contraceptives and
Recruiting
- HIV Infections
- +2 more
- Etonogestrel (ETG) implant
- +3 more
-
Johannesburg, South AfricaWits Reproductive Health and HIV Institute, Research Centre Clin
Feb 28, 2022
Menopausal Syndromes Trial in Banqiao (Tibolone, Estradiol & medroxyprogesterone acetate)
Completed
- Menopausal Syndromes
- Tibolone
- Estradiol & medroxyprogesterone acetate
-
Banqiao, New Taipei, TaiwanFar Eastern Memorial Hospital
Feb 7, 2022
Pregnancy, Contraception Trial in Philadelphia, Norfolk (TV-46046 - 400 mg/mL, TV-46046 - 200 mg/mL, TV-46046 - 300 mg/mL (if
Completed
- Pregnancy
- Contraception
- TV-46046 - 400 mg/mL
- +2 more
-
Philadelphia, Pennsylvania
- +1 more
Nov 5, 2021
Human Immunodeficiency Virus, Contraception, ART Trial in Gaborone (Dolutegravir, Levonorgestrel implant, Depo
Recruiting
- Human Immunodeficiency Virus
- +2 more
- Dolutegravir
- +2 more
-
Gaborone, BotswanaPrincess Marina Hospital
Mar 1, 2022
Quick Start of Highly Effective Contraception
Active, not recruiting
- IUD
- +4 more
- Copper T-380 IUD
- +3 more
-
West Valley City, UtahPlanned Parenthood Association of Utah
May 4, 2022
Metrorrhagia Trial in New York (Femring®, DepoProvera ®)
Completed
- Metrorrhagia
- Femring®
- DepoProvera ®
-
New York, New YorkTitle X Family Planning Clinic
Dec 7, 2021
Pregnancy Rates, PK Interactions Among HIV+ Women on EFV
Completed
- HIV Infections
-
Lilongwe, MalawiUNC Project
Feb 23, 2022
Mucosal Inflammation, Contraceptive; Complications, Intrauterine Trial in Norfolk, Thika (Copper IUD, Etonogestrel implant,
Recruiting
- Mucosal Inflammation
- Contraceptive; Complications, Intrauterine
- Copper IUD
- +3 more
-
Norfolk, Virginia
- +1 more
Apr 7, 2022
Contraception Trial in Santo Domingo (TV-46046, Depo-subQ 104, TV-46046 Placebo)
Completed
- Contraception
- TV-46046
- +2 more
-
Santo Domingo, Dominican RepublicTeva Investigational Site 1
Nov 18, 2021
Sites to Test Whether SAMANTA Questionnaire That is Used to
Completed
- Menorrhagia
- Chronic hormonal treatment
-
Multiple Locations, SpainMany locations
Mar 29, 2022